"Health care is more than annual check-up or flu vaccination. It's a long-term relationship with a physician who cares about you and your health. The Providence Medical Group physician network includes a team of compassionate, experienced healthcare professionals who are here for you and everyone in your family providing expert care, close to home. With conveniently located practices, the Providence Medical Group has a broad network of physicians who include primary care physicians, cardiologists, general surgeons, OB/GYN specialists, pain management specialists and urologists."

During the past decade, Providence Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 31 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 25 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Gynecologic Oncology Group" with 7 trials sponsored, "GOG Foundation" with 3 trials sponsored and "Radiation Therapy Oncology Group" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Providence Medical Center" are "Fallopian Tube Clear Cell Adenocarcinoma" (4 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (4 trials), "Fallopian Tube Mucinous Adenocarcinoma" (4 trials), "Fallopian Tube Serous Adenocarcinoma" (4 trials) and "Fallopian Tube Transitional Cell Carcinoma" (4 trials). Many other conditions were trialed in "Providence Medical Center" in a lesser frequency.

Most popular intervention types in "Providence Medical Center" are "Drug" (41 trials), "Other" (30 trials), "Biological" (20 trials), "Radiation" (9 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (12 trials), "Bevacizumab" (9 trials), "Carboplatin" (9 trials) and "Cisplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Providence Medical Center" are 29 trials for "All" genders, 19 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Medical Center". undefined are not yet recruiting, 1 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Providence Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Medical Center, 3 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".